Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1992-06-30
1993-03-30
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
514 12, 514 13, 514 8, 530397, 5303872, 53038824, 5303892, A61K 3704, A61K 3702
Patent
active
051984202
ABSTRACT:
The use of agonists or antagonists of Mullerian Inhibiting Substance to suppress or treat respiratory distress syndrom. The treatment can be accomplished by providing an effective amount of the agonist or antagonist to a neonatal or prenatal individual.
REFERENCES:
Catlin, E. A. et al., Am J. Obstet. Gynecol. 159: 1299-1303 (1988).
Catterton, W. Z. et al., Pediatr. Res. 13:104-108 (1979).
Coughlin, J. P. et al., Mol. Cell Endocrinol. 49:75-86 (1987).
Hutson, J. M. et al., Endocrinology, 113:1470-1475 (1983).
Hutson, J. M. et al., Science, 223:586-589 (1984).
Nielsen, H. C. et al., J. Clin. Invest., 69:611-616 (1982).
Nielsen, H. C. Am. Rev. Respir. Dis., 137:275 (1988).
Odom, M. J. et al., Endocrinology, 113:1470-1475 (1983).
Pepinsky, R. B. et al., J. Biol. Chem., 263:18961-18964 (1988).
Post, M. et al., J. Biol. Chem., 261:2179-2184 (1986).
Rooney, S. A. et al., Biochim. Biophys. Acta., 450:121-130 (1976).
Snyder, J. M. et al., Cell Tissue Res., 220:17-25 (1981).
Sundell, H. W. et al., Am. J. Pathol., 100:707-726 (1980).
Torday, J. S. et al., Am. Rev. Respir. Dis., 123:205-208 (1981).
Torday, J. S. et al., Biochim. Biophys Acta., 835:23-28 (1985).
Ueno, S. et al., Endocrinology, 128:1652-1659 (1988).
Whitsett, J. A. et al., J. Biol. Chem., 262:7908-7913 (1987).
Catlin Elizabeth A.
Donahoe Patricia K.
Cashion Jr. Merrell C.
Koh Choon P.
The General Hospital Corporation
LandOfFree
Use of mullerian inhibiting substance and its agonists and antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mullerian inhibiting substance and its agonists and antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mullerian inhibiting substance and its agonists and antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281080